focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DEALINGS IN SECURITIES BY DIRECTORS AND SECRETARY

17 Jun 2020 11:00

RNS Number : 2280Q
Stenprop Limited
17 June 2020
 

 

 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

 

 

DEALINGS IN SECURITIES BY DIRECTORS AND BY THE COMPANY SECRETARY

 

17 June 2020

 

Shareholders are advised of the following information relating to the acceptance of nil cost options and market value options awarded on 12 June 2020 under the Stenprop Limited Long-Term Incentive Plan (the "LTIP"). The nil cost options will vest on 12 June 2023 subject to certain vesting conditions having been met, including performance targets set by the remuneration committee prior to the awards being made. Assuming that the performance targets are met in full at the end of the performance period, the nil cost options will result in the issue of 1,052,230 shares. The market value options will vest in three tranches on 31 March 2021, 31 March 2022 and 31 March 2023 and once fully vested will result in the issue of 182,375 shares subject to the payment of the exercise price of £1.0492 per share.

 

Name of director:

Paul Arenson

Transaction date:

12 June 2020

Class of securities:

Nil cost options

Number of securities:

536,599

Nature of transaction

Off-market acceptance of nil cost options in terms of the LTIP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of director:

Julian Carey

Transaction date:

12 June 2020

Class of securities:

Nil cost options

Number of securities:

515,631

Nature of transaction:

Off-market acceptance of nil cost options in terms of the LTIP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of director:

James Beaumont

Transaction date:

12 June 2020

Class of securities:

Market value options

Number of securities:

102,932

Total price payable on exercise:

£107,996.25

Nature of transaction:

Off-market acceptance of market value options in terms of the LTIP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of company secretary:

Sarah Bellilchi

Transaction date:

12 June 2020

Class of securities:

Market value options

Number of securities:

79,443

Total price payable on exercise:

£83,351.60

Nature of transaction:

Off-market acceptance of market value options in terms of the LTIP

Nature and extent of company secretary's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Shareholders are further advised of the following information relating to the acceptance of nil cost options awarded on 12 June 2020 under the Stenprop Limited Deferred Bonus Plan (the "DBP"). One third of these nil cost options vested immediately, with the second third vesting on 31 March 2021 and the last third vesting on 31 March 2022. Once fully vested, they will result in the issue of 71,124 shares.

 

 

 

Name of director:

Paul Arenson

Transaction date:

12 June 2020

Class of securities:

Nil cost options

Number of securities:

29,712

Nature of transaction:

Off-market acceptance of nil cost options in terms of the DBP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of director:

Julian Carey

Transaction date:

12 June 2020

Class of securities:

Nil cost options

Number of securities:

28,558

Nature of transaction:

Off-market acceptance of nil cost options in terms of the DBP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of director:

James Beaumont

Transaction date:

12 June 2020

Class of securities:

Nil cost options

Number of securities:

9,768

Nature of transaction:

Off-market acceptance of nil cost options in terms of the DBP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

Name of company secretary:

Sarah Bellilchi

Transaction date:

12 June 2020

Class of securities:

Nil cost options

Number of securities:

3,086

Nature of transaction:

Off-market acceptance of nil cost options in terms of the DBP

Nature and extent of director's interest:

Direct beneficial

Clearance to deal received:

Yes

 

 

For further information:

 

Stenprop Limited +44(0)20 3918 6600

Paul Arenson (paul.arenson@stenprop.com)

Julian Carey (julian.carey@stenprop.com)

James Beaumont (james.beaumont@stenprop.com)

 

Numis Securities Limited (Financial Adviser) +44(0)20 7260 1000

Hugh Jonathan

Vicki Paine

Justin Bell

 

FTI Consulting +44(0)20 3727 1000

Richard Sunderland stenprop@fticonsulting.com

Richard Gotla

Indraneel Bose

 

Java Capital Trustees and Sponsors Proprietary Limited +27 (0)11 722 3050

(JSE Sponsor)

 

About Stenprop:

 

Stenprop is a UK REIT listed on the LSE and the JSE. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to stenprop.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHVDLBFBQLFBBK
Date   Source Headline
13th Feb 20207:00 amRNSPortfolio Update
5th Feb 202012:30 pmRNSTransaction in Own Shares
29th Jan 202012:00 pmRNSDirector/PDMR Shareholding
27th Jan 20203:00 pmRNSPosting of circular and notice of general meeting
14th Jan 20207:00 amRNSScrip dividend finalisation
30th Dec 20197:00 amRNSDirector/PDMR Shareholding
20th Dec 201910:00 amRNSDirector/PDMR Shareholding
19th Dec 20192:30 pmRNSElection to receive cash or scrip dividend
18th Dec 201912:00 pmRNSDisposal of Bleichenhof
22nd Nov 20197:01 amRNSSummarised half-year report
22nd Nov 20197:00 amRNSHalf-year Report
8th Nov 201912:00 pmRNSNotice of Results
25th Oct 20197:00 amRNSTrading update
18th Oct 20197:00 amRNSAcquisition of multi-let industrial estates
26th Sep 20197:00 amRNSAcquisition of multi-let industrial properties
20th Sep 20193:45 pmRNSResult of AGM
20th Sep 20197:00 amRNSAcquisition of multi-let industrial estates
6th Sep 201911:00 amRNSDirector/PDMR Shareholding
22nd Aug 201910:00 amRNSDirector/PDMR Shareholding
16th Aug 201910:00 amRNSDirector/PDMR Shareholding
15th Aug 20197:00 amRNSResult of election for cash or scrip dividend
9th Aug 20199:00 amRNSTransaction in Own Shares
6th Aug 20197:00 amRNSTrading update
2nd Aug 20193:30 pmRNSTransaction in Own Shares
31st Jul 20193:00 pmRNSNotice of AGM
19th Jul 20197:00 amRNSTRANSACTION IN OWN SHARES
18th Jul 20197:00 amRNSTransaction in Own Shares
16th Jul 201910:00 amRNSELECTION TO RECEIVE A CASH OR A SCRIP DIVIDEND
10th Jul 20198:00 amRNSDirector/PDMR Shareholding - amendment
9th Jul 20193:00 pmRNSScrip dividend circular
8th Jul 20192:00 pmRNSDirector/PDMR Shareholding
27th Jun 20193:00 pmRNSPosting of annual report and no change statement
10th Jun 20193:45 pmRNSDirector/PDMR Shareholding
6th Jun 20197:00 amRNSFinal Results
5th Jun 20193:30 pmRNSAppointment of interim CFO
17th May 20197:00 amRNSNotice of Results
3rd Apr 201912:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20197:00 amRNSAppointment of JSE-accredited auditor
14th Mar 20192:45 pmRNSTransaction in Own Shares
14th Mar 20197:00 amRNSCompletion of disposal of Euston House
13th Mar 201911:00 amRNSTransaction in Own Shares
12th Mar 20191:00 pmRNSDirector/PDMR Shareholding
12th Mar 20197:00 amRNSAcquisition of multi-let industrial estate
11th Mar 201910:00 amRNSTransaction in Own Shares
8th Mar 201910:00 amRNSTransaction in Own Shares
28th Feb 20197:00 amRNSTransaction in Own Shares
13th Feb 20197:00 amRNSTransaction in Own Shares
12th Feb 20191:00 pmRNSDEALING IN SECURITIES BY DIRECTOR OF THE COMPANY
12th Feb 20197:00 amRNSTransaction in Own Shares
11th Feb 20197:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.